IE782179L - 4-amino-2-(piperazin-1-yl or hompiperazin-1-yl) quinazoline¹derivatives - Google Patents

4-amino-2-(piperazin-1-yl or hompiperazin-1-yl) quinazoline¹derivatives

Info

Publication number
IE782179L
IE782179L IE782179A IE217978A IE782179L IE 782179 L IE782179 L IE 782179L IE 782179 A IE782179 A IE 782179A IE 217978 A IE217978 A IE 217978A IE 782179 L IE782179 L IE 782179L
Authority
IE
Ireland
Prior art keywords
radical
lower alkoxy
hydrogen atom
different
lower alkyl
Prior art date
Application number
IE782179A
Other versions
IE47888B1 (en
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of IE782179L publication Critical patent/IE782179L/en
Publication of IE47888B1 publication Critical patent/IE47888B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention relates to novel derivatives of 4-amino-3-(piperazin-1-yl or homopiperazin-1-yl)quinazoline, which can be used as regulators of the cardiovascular system, and are especially suitable for treating high blood pressure. The compounds have the formula I <IMAGE> in which (R)n represents a 6,7-di(lower alkoxy) or 6,7,8-tri(lower alkoxy) radical; m = 1 or 2, X represents the radical -CHR<1>- or -CH2CH2-; each of the radicals R<1>, which may be identical or different to the others, represents a hydrogen atom or a lower alkyl radical; and R<2> and R<3>, which may be identical or different, each represent a hydrogen atom, a lower alkyl radical, lower alkoxy radical, a halogen atom, a lower alkanoyl radical, lower alkoxy carbonyl radical or a radical of the formula -CONR<4>R<5> or -SO2NR<4>R<5>, in which R<4> and R <5>, which may be identical or different, each represent a hydrogen atom or a lower alkyl radical; the compounds may also be present in the form of their pharmaceutically acceptable acid addition salts. [FR2407929A1]
IE2179/78A 1977-11-05 1978-11-03 4-amino-2-(piperazin-1-yl or homopiperazin-1-yl) quinazoline derivatives IE47888B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4612877 1977-11-05

Publications (2)

Publication Number Publication Date
IE782179L true IE782179L (en) 1979-05-05
IE47888B1 IE47888B1 (en) 1984-07-11

Family

ID=10439957

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2179/78A IE47888B1 (en) 1977-11-05 1978-11-03 4-amino-2-(piperazin-1-yl or homopiperazin-1-yl) quinazoline derivatives

Country Status (36)

Country Link
JP (1) JPS5498792A (en)
AR (2) AR219562A1 (en)
AT (1) AT365186B (en)
AU (1) AU509329B2 (en)
BE (1) BE871771A (en)
CA (1) CA1088059A (en)
CH (1) CH643255A5 (en)
CS (2) CS207671B2 (en)
DD (1) DD139850A5 (en)
DE (1) DE2847623C2 (en)
DK (1) DK154082C (en)
EG (1) EG13594A (en)
ES (2) ES474805A1 (en)
FI (1) FI64366C (en)
FR (1) FR2407929A1 (en)
GR (1) GR81514B (en)
HK (1) HK94284A (en)
HU (1) HU176306B (en)
IE (1) IE47888B1 (en)
IL (1) IL55857A (en)
IN (1) IN148828B (en)
IT (1) IT1100919B (en)
KE (1) KE3350A (en)
LU (2) LU80470A1 (en)
MY (1) MY8500286A (en)
NL (2) NL174549C (en)
NO (1) NO150158C (en)
NZ (1) NZ188813A (en)
PH (1) PH13966A (en)
PL (2) PL119419B1 (en)
PT (1) PT68735A (en)
SE (1) SE437518B (en)
SU (1) SU816403A3 (en)
UA (1) UA8324A1 (en)
YU (2) YU40204B (en)
ZA (1) ZA786184B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002644A1 (en) * 1984-11-01 1986-05-09 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985004658A1 (en) * 1984-04-04 1985-10-24 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepine derivatives and their preparation
WO1985002617A1 (en) * 1983-12-14 1985-06-20 Takeda Chemical Industries. Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
PT849266E (en) * 1996-12-20 2007-03-30 Heumann Pcs Gmbh Novel polymorphic form of doxazosin mesylate (form iii)
EP0849265A1 (en) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Novel polymorphic form of doxazosin mesylate (form II)
EP0849264A1 (en) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Novel polymorphic form of doxazosin mesylate (form I)
TW448155B (en) * 1999-03-29 2001-08-01 Dev Center Biotechnology Method for producing amide compounds and quinazolin derivatives
EP1403263B1 (en) * 2002-09-27 2005-06-22 Council of Scientific and Industrial Research Process for the preparation of N-(2,3-dihydrobenzo 1,4 dioxin-2-carbonyl) piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
DK154082C (en) 1989-02-27
NL7810909A (en) 1979-05-08
YU255378A (en) 1983-06-30
AR223015A1 (en) 1981-07-15
FR2407929B1 (en) 1981-02-27
CS207671B2 (en) 1981-08-31
FR2407929A1 (en) 1979-06-01
FI64366C (en) 1983-11-10
NL174549C (en) 1984-07-02
IL55857A0 (en) 1979-01-31
ES8308559A1 (en) 1980-07-16
SE7811382L (en) 1979-05-06
YU40204B (en) 1985-08-31
NL174549B (en) 1984-02-01
AU509329B2 (en) 1980-05-08
YU38683A (en) 1983-06-30
ES480121A0 (en) 1980-07-16
MY8500286A (en) 1985-12-31
NO150158B (en) 1984-05-21
NZ188813A (en) 1980-10-08
PL119419B1 (en) 1981-12-31
AU4132278A (en) 1979-05-17
JPS5498792A (en) 1979-08-03
UA8324A1 (en) 1996-03-29
IL55857A (en) 1982-07-30
FI783347A (en) 1979-05-06
EG13594A (en) 1982-03-31
ATA784378A (en) 1981-05-15
CS354491A3 (en) 1992-06-17
YU40419B (en) 1985-12-31
NO783705L (en) 1979-05-08
NL930062I1 (en) 1993-09-01
DE2847623C2 (en) 1983-06-01
FI64366B (en) 1983-07-29
GR81514B (en) 1984-12-11
PH13966A (en) 1980-11-12
SE437518B (en) 1985-03-04
DD139850A5 (en) 1980-01-23
KE3350A (en) 1983-12-16
AT365186B (en) 1981-12-28
IN148828B (en) 1981-06-27
CH643255A5 (en) 1984-05-30
LU80470A1 (en) 1980-06-05
AR219562A1 (en) 1980-08-29
SU816403A3 (en) 1981-03-23
IT7829434A0 (en) 1978-11-03
JPS5625233B2 (en) 1981-06-11
CA1088059A (en) 1980-10-21
HU176306B (en) 1981-01-28
DK428678A (en) 1979-05-06
ZA786184B (en) 1979-10-31
ES474805A1 (en) 1980-01-16
NL930062I2 (en) 1993-11-16
IT1100919B (en) 1985-09-28
PT68735A (en) 1978-12-01
PL119586B1 (en) 1982-01-30
IE47888B1 (en) 1984-07-11
PL210681A1 (en) 1979-11-05
DK154082B (en) 1988-10-10
DE2847623A1 (en) 1979-05-23
HK94284A (en) 1984-12-07
NO150158C (en) 1984-08-29
LU88331I2 (en) 1994-05-04
BE871771A (en) 1979-05-03

Similar Documents

Publication Publication Date Title
DE19475017I2 (en) Mevalolactone analogs and derivatives Process for the preparation of pharmaceutical compositions containing them and their use as medicines
ES8703150A1 (en) New B-Carboline-3-oxadiazolyl derivatives, method of preparing the same and their use.
EP0398720A3 (en) Piperazine derivatives
IE782179L (en) 4-amino-2-(piperazin-1-yl or hompiperazin-1-yl) quinazoline¹derivatives
ES8603184A1 (en) B-Carboline-3-carboxylic acid derivatives, method of preparing the same and their use.
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
DE3164314D1 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
JPS52106897A (en) Synthesis of piperazine derivatives
GB2007656A (en) 4-amino-2-(piperazin-1-yl or homopiperazin-1-yl) quinazoline derivatives
ATE41659T1 (en) BENZOTHIAZEPINE DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
EP0169009A3 (en) Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
ES466168A1 (en) Chromone derivatives
ES8201979A1 (en) Biphenylyl-imidazolylethane derivatives, process for their preparation and medicaments containing them.
JPS5331669A (en) Novel n-acylpiperidinecaroxyanilide derivatives and their preparation
ES8206550A1 (en) 2%-Deoxy-3%,5%-di-O- alkylcarbonyl-5-fluorouridine derivatives, a process for the preparation of the derivatives and anti-tumor agents containing the derivatives
ES473038A1 (en) 2-Guanidinomethyl-indolines, method for their preparation and their pharmaceutical use.
JPS5239674A (en) Imidazole derivatives and agricultural bactericides therefrom
JPS5424869A (en) Heterocyclic compounds and their preparation
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
JPS5387330A (en) Novel thiohydroxymate derivative, its preparation and bactericideand herbicide containing the same
ATE28859T1 (en) DERIVATIVES OF AMINONAPHTHACENES AND PROCESS FOR THEIR PRODUCTION.
JPS5414961A (en) Novel 3-hydroxyazetidine-3-carboxylic derivative
JPS5247027A (en) Preparation of monoazomethine pigment of barbituric acid
JPS5262285A (en) Preparation of n1 2&#39;-ethoxy) furanidyl uracil derivatives
ES8407047A1 (en) Carboline derivatives.

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 29/93:19930603

SPCG Supplementary protection certificate granted

Free format text: SPC 29/93 EXPIRES:20020401